Long-term Follow-up of antithrombotIc Management Patterns in Acute Coronary Syndrome Patients in Asia-China Extension

AstraZeneca2,334 enrolled

Overview

This study is to describe the long-term antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome in China.

This study is to describe the long-term (3 to 5 years after the acute coronary syndrome index event) antithrombotic management patterns in a real-life setting for patients hospitalized with an acute coronary syndrome (i.e. ST-segment Elevation Myocardial Infarction, Non-ST-segment Elevation Myocardial Infarction, Unstable Angina) in China.

Study Type

OBSERVATIONAL

Enrollment

2,334

Conditions

Acute Coronary Syndromes

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. Written informed consent has been provided. 2. Contact Order Form has been provided 3. Aged 18 years or older. 4. Enrolled in EPICOR Asia study and completed the 2 year follow-up. Exclusion Criteria: 1. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances, alcohol or drug abuse). 2. Already included in the EPICOR Asia-China Extension observational study. 3. Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy. 4. Current participation in an interventional clinical trial. 5. Patients receiving ticagrelor beyond 12 months and other off label use.

Locations (33)

Research Site

Baoding, China

Outcomes

Primary Outcomes

Long-term antithrombotic management patterns in a real-life setting by assessing the medication and treatment prescribed by physicians

Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

Secondary Outcomes

Clinical outcomes by record the number and type of cardiovascular and non-cardiovascular events

Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

Health care resource consumption and related costs by assessing the detail hospitalization and outpatient cost.

Time frame: From 2 years after the acute coronary syndrome index event, assessed up to 5 years

Quality of life by assessing EQ-5D questionnaire.

Time frame: 2 years,2.5years,3years,3.5years,4years,4.5years,5years after the acute coronary syndrome index event

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.